What You Should Know:
- Surescripts Health Information Network, a subsidiary of Surescripts®, today announced its designation as a Qualified Health Information Network® (QHIN) by the Recognized Coordinating Entity® (RCE®), The Sequoia Project, Inc.
- The designation allows Surescripts Health Information Network to facilitate nationwide health data exchange under the governance of the Trusted Exchange Framework and Common Agreement (TEFCA) policies and technical requirements.
Read More
GeneDx Acquires Fabric Genomics for $33M, Expanding Access to AI-Powered Genomic Interpretation
What You Should Know:
- GeneDx, a company focused on improving health outcomes through genomic insights, has announced its plans to acquire Fabric Genomics, a pioneer in AI-powered genomic interpretation.
- The acquisition aims to position GeneDx at the forefront of the next phase of genomic medicine, characterized by decentralized testing with centralized intelligence. Following the closing of the acquisition, Fabric Genomics will initially operate independently while
Read More
Assort Health Raises $26M for Specialty-Specific GenAI Platform for Managing Patient Phone Calls
What You Should Know:
- Assort Health, a company specializing in AI solutions for managing patient phone calls in healthcare, has announced a new round of institutional financing co-led by First Round Capital and Chemistry, with continued support from existing investor Quiet Capital, bringing the company's total funding to $26M.
- The funding will be used to accelerate Assort Health's mission of improving access to care by addressing the issues of long hold times and scheduling
Read More
The Future of Health Systems: Consolidation, Technology, and a New Operating Model
What You Should Know:
- A new study by HFS Research, in partnership with Cognizant, examines the evolving landscape of US healthcare delivery, focusing on health system consolidation and the strategies necessary for success.
- The study, which includes insights from over 150 health system CXOs, paints a picture of an industry facing significant challenges and undergoing rapid transformation.
Key Challenges and Transformations
US health systems are adapting to deliver
Read More
Synapse Health Appoints Mandira Singh as President
What You Should Know:
- Synapse Health, a company focused on advancing the durable medical equipment (DME) industry toward value-based care, has announced the appointment of Mandira Singh as its new president.
- Singh initially joined Synapse Health in August as a senior advisor and is now becoming part of the company's expanding executive team. This team is focused on modernizing the DME ecosystem to better serve patients, prescribers, and DME provider
Read More
RadNet to Acquire iCAD for $103M in All-Stock Transaction
What You Should Know:
- RadNet, Inc., a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, and iCAD, Inc., a global leader in AI-powered breast health solutions, announced that they have entered into a definitive merger agreement.
- Under the agreement, RadNet will acquire iCAD for $103M in an all-stock transaction.
Financial Details
Based on RadNet’s closing price on Monday, April 14, 2025, the transaction
Read More
World’s First AI Lung Sound Suite: TytoCare Gets FDA Clearance for Rhonchi
What You Should Know:
- TytoCare, a pioneering virtual care company dedicated to delivering accessible, high-quality primary care from the comfort of home announced the company has become the first in the world to receive FDA clearance for its AI-based detection of all three major abnormal lung sounds.
- The milestone was reached with the FDA clearance of Tyto Insights™ for Rhonchi Detection, completing TytoCare’s comprehensive AI-powered lung sound suite. With this latest
Read More
Click Therapeutics Obtains FDA Authorization for First Prescription Digital Therapeutic for Migraine Prevention
What You Should Know:
- Click Therapeutics, Inc. (“Click”), a leader in the rapidly evolving field of prescription medical treatments, encompassing both prescription digital therapeutics (PDTs) and software-enhanced drug™ therapies has received FDA marketing authorization for CT-132, the first prescription digital therapeutic specifically indicated for the preventive treatment of episodic migraine in adults aged 18 and older.
- The FDA granted a De Novo Classification Request for
Read More
Intelerad Appoints Eric Grunden as New Chief Customer Officer
What You Should Know:
- Intelerad, a global leader in medical imaging software solutions announced the appointment of Eric Grunden as its new Chief Customer Officer.
- In this pivotal role, Grunden will spearhead key initiatives aimed at significantly enhancing the overall client experience, optimizing support systems, and driving operational excellence across all client-facing teams within the organization.
Grunden's leadership will be instrumental in ensuring improved
Read More
PGxAI Launches Deneb: AI Model Revolutionizing Drug Development with Pharmacogenetics
What You Should Know:
- PGxAI, a pioneering leader in the field of AI-driven pharmacogenetics, today announced the launch of Deneb, its latest cutting-edge model poised to transform the landscape of drug development.
- Deneb is specifically designed to streamline this complex process by seamlessly integrating molecular structures, physicochemical properties, and comprehensive genetic profiles.
Drug Development for Biopharma
Tailored to meet the critical needs of
Read More
